Showing 1 - 16 results of 16 for search 'Goodall, R', query time: 0.03s
Refine Results
-
1
-
2
Designing HTS coils for magnetic circuits by Jenkins, R, Jones, H, Goodall, R
Published 1996Conference item -
3
Progress in high-T-c magnet development in Oxford by Jones, H, Richens, P, Ryan, D, Goodall, R
Published 1998Conference item -
4
Electro-epitaxial buffer layers for REBCO tape architectures by Whiteley, R, Goodall, R, Moore, J, Speller, S, Grovenor, C
Published 2003Conference item -
5
Fabrication of cube-textured Ag-buffered Ni substrates by electro-epitaxial deposition by Goodall, R, Moore, J, Pecz, B, Grime, G, Salter, C, Grovenor, C
Published 2001Journal article -
6
CONTROL ASPECTS OF SUPERCONDUCTING MAGNETS FOR MAGNETIC SUSPENSIONS AND BEARINGS by Goodall, R, Macleod, C, Elabbar, A, Campbell, A, Jones, H, Jenkins, R
Published 1995Conference item -
7
Epidermal growth factor receptor blockers for the treatment of ovarian cancer by Morrison, J, Thoma, C, Goodall, R, Lyons, T, Gaitskell, K, Wiggans, A, Bryant, A
Published 2018Journal article -
8
Dynamic characteristics of iron-cored magnets using high-T-c superconductors by ElAbbar, A, Goodall, R, MacLeod, C, Campbell, A, Jenkins, R, Jones, H
Published 1995Conference item -
9
Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting. by McCormick, A, Goodall, R, Joyce, A, Ndembi, N, Chirara, M, Katundu, P, Walker, S, Yirrell, D, Gilks, C, Pillay, D
Published 2010Journal article -
10
-
11
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria by Gilks, C, Walker, A, Munderi, P, Kityo, C, Reid, A, Katabira, E, Goodall, R, Grosskurth, H, Mugyenyi, P, Hakim, J, Gibb, D
Published 2013Journal article -
12
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the... by Kityo, C, Gibb, D, Gilks, C, Goodall, R, Mambule, I, Kaleebu, P, Pillay, D, Kasirye, R, Mugyenyi, P, Walker, A, Dunn, D
Published 2014Journal article -
13
Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial. by Holodniy, M, Brown, S, Cameron, D, Kyriakides, T, Angus, B, Babiker, A, Singer, J, Owens, D, Anis, A, Goodall, R, Hudson, F, Piaseczny, M, Russo, J, Schechter, M, Deyton, L, Darbyshire, J
Published 2011Journal article -
14
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine... by Ndembi, N, Ndembi, N, Goodall, R, Dunn, D, McCormick, A, Burke, A, Lyagoba, F, Munderi, P, Katundu, P, Kityo, C, Robertson, V, Yirrell, D, Walker, A, Gibb, D, Gilks, C, Kaleebu, P, Pillay, D
Published 2010Journal article -
15
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium. by Bart, P, Goodall, R, Barber, T, Harari, A, Guimaraes-Walker, A, Khonkarly, M, Sheppard, N, Bangala, Y, Frachette, M, Wagner, R, Liljeström, P, Kraehenbuhl, J, Girard, M, Goudsmit, J, Esteban, M, Heeney, J, Sattentau, Q, McCormack, S, Babiker, A, Pantaleo, G, Weber, J
Published 2008Journal article -
16
Secretions from placenta, after hypoxia/reoxygenation, can damage developing neurones of brain under experimental conditions. by Curtis, D, Sood, A, Phillips, T, Leinster, V, Nishiguchi, A, Coyle, C, Lacharme-Lora, L, Beaumont, O, Kemp, H, Goodall, R, Cornes, L, Giugliano, M, Barone, R, Matsusaki, M, Akashi, M, Tanaka, H, Kano, M, McGarvey, J, Halemani, N, Simon, K, Keehan, R, Ind, W, Masters, T, Grant, S, Athwal, S
Published 2014Journal article